array(3) { ["company_details"]=> array(13) { ["name"]=> string(28) "Bristol-Myers Squibb Company" ["slug"]=> string(37) "81631-us-bristol-myers-squibb-company" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13" ["description"]=> string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html" ["address_street"]=> string(19) "430 E 29TH St FL 14" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1887-02-28" ["website_domain"]=> string(7) "bms.com" ["website_url"]=> string(19) "https://www.bms.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(1200) ["article_count"]=> int(2495) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(78) "IDTechEx Release New Global Advanced Li-ion Battery Technologies Market Report" ["snippet_en"]=> string(193) "BOSTON, April 5, 2024 /PRNewswire/ -- IDTechEx Research, a trusted provider of independent market intelligence, announces the availability of a new report, "Advanced Li-ion Battery Technologies" ["url"]=> string(148) "https://www.finanznachrichten.de/nachrichten-2024-04/61875358-idtechex-release-new-global-advanced-li-ion-battery-technologies-market-report-008.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f3c00f48-8b76-46ac-96f8-fa9ed003d89b" ["source"]=> string(20) "finanznachrichten.de" ["publication_date"]=> string(10) "2024-04-05" ["categories"]=> array(2) { [0]=> string(5) "R & D" [1]=> string(18) "Business Structure" } } [1]=> array(7) { ["title_en"]=> string(96) "Albumin-bound Paclitaxel Market An Professional Research Report 2024-2030 | Survey by QYResearch" ["snippet_en"]=> string(96) "Albumin-bound Paclitaxel Market An Professional Research Report 2024-2030 | Survey by QYResearch" ["url"]=> string(153) "https://industrytoday.co.uk/market-research-industry-today/albumin-bound-paclitaxel-market-an-professional-research-report-2024-2030-survey-by-qyresearch" ["image_url"]=> NULL ["source"]=> string(19) "industrytoday.co.uk" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(4) { [0]=> string(17) "Academic Research" [1]=> string(5) "R & D" [2]=> string(15) "Market Movement" [3]=> string(19) "Economic Conditions" } } [2]=> array(7) { ["title_en"]=> string(83) "Nivolumab by Bristol-Myers Squibb for Hypopharyngeal Cancer: Likelihood of Approval" ["snippet_en"]=> string(116) "Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Hypopharyngeal Cancer." ["url"]=> string(132) "https://www.pharmaceutical-technology.com/data-insights/nivolumab-bristol-myers-squibb-hypopharyngeal-cancer-likelihood-of-approval/" ["image_url"]=> NULL ["source"]=> string(29) "pharmaceutical-technology.com" ["publication_date"]=> string(10) "2024-01-22" ["categories"]=> array(2) { [0]=> string(5) "R & D" [1]=> string(26) "Product Quality and safety" } } [3]=> array(7) { ["title_en"]=> string(46) "BMS shows its commitment to psoriasis research" ["snippet_en"]=> string(154) "The pharmaceutical company Bristol Myers Squibb has presented its more than 20 years of experience in immunological research at the 9th Psoriasis Congress" ["url"]=> string(116) "https://www.consalud.es/industria/bms-muestra-compromiso-investigacion-nuevos-tratamientos-psoriasis_139203_102.html" ["image_url"]=> NULL ["source"]=> string(11) "consalud.es" ["publication_date"]=> string(10) "2024-01-19" ["categories"]=> array(2) { [0]=> string(17) "Academic Research" [1]=> string(5) "R & D" } } [4]=> array(7) { ["title_en"]=> string(67) "BeiGene’s New Manufacturing and Clinical R&D Centre, Hopewell, US" ["snippet_en"]=> string(168) "BeiGene, a biotechnology company based in the US, is building a new manufacturing campus and clinical research and development (R&D) centre in Hopewell, New Jersey, US." ["url"]=> string(114) "https://www.pharmaceutical-technology.com/projects/beigenes-new-manufacturing-and-clinical-rd-centre-hopewell-usa/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/98b1bc21-48d3-4d01-94b8-b0d9186317bc" ["source"]=> string(29) "pharmaceutical-technology.com" ["publication_date"]=> string(10) "2024-01-15" ["categories"]=> array(2) { [0]=> string(5) "R & D" [1]=> string(18) "Expansion & Growth" } } [5]=> array(7) { ["title_en"]=> string(68) "iBattMan project will create a smart battery management BMS platform" ["snippet_en"]=> string(163) "Within the framework of the new iBattMan project (Intelligent, connected and secure battery management system enhanced by NextGeneration Edge and Cloud Computing)," ["url"]=> string(109) "https://www.smartgridsinfo.es/2024/01/15/proyecto-ibattman-creara-plataforma-bms-gestion-baterias-inteligente" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a5159174-86c0-4beb-94ce-53d4a4ccd12b" ["source"]=> string(17) "smartgridsinfo.es" ["publication_date"]=> string(10) "2024-01-15" ["categories"]=> array(6) { [0]=> string(14) "Product Launch" [1]=> string(37) "Product Design & Lifecycle Management" [2]=> string(5) "R & D" [3]=> string(13) "Collaboration" [4]=> string(13) "Data Security" [5]=> string(20) "Business Development" } } [6]=> array(7) { ["title_en"]=> string(74) "BMS will pay up to $8.4 billion for development of antibody-drug conjugate" ["snippet_en"]=> string(88) "The company entered into an agreement with a subsidiary of Sichuan Biokin Pharmaceutical" ["url"]=> string(126) "https://pharmvestnik.ru/content/news/BMS-vyplatit-do-8-4-mlrd-doll-za-razrabotku-konugata-antitelo-lekarstvennoe-sredstvo.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b969e1e8-f771-4dca-bb82-e3c7786dacd6" ["source"]=> string(15) "pharmvestnik.ru" ["publication_date"]=> string(10) "2023-12-12" ["categories"]=> array(5) { [0]=> string(15) "Corporate Fines" [1]=> string(8) "Verdicts" [2]=> string(16) "Case Settlements" [3]=> string(5) "R & D" [4]=> string(13) "Collaboration" } } [7]=> array(7) { ["title_en"]=> string(86) "Vitesco Technologies México: Development of innovative electric mobility technologies" ["snippet_en"]=> string(47) "Design wireless charging BMS for electric cars." ["url"]=> string(132) "https://www.portalautomotriz.com/noticias/proveedores/vitesco-technologies-mexico-desarrollo-de-tecnologias-innovadoras-de-movilidad" ["image_url"]=> string(78) "https://images.businessradar.com/articles/54558dca-21d6-418c-ab19-7e734c8e655c" ["source"]=> string(20) "portalautomotriz.com" ["publication_date"]=> string(10) "2023-12-11" ["categories"]=> array(6) { [0]=> string(13) "GHG Emissions" [1]=> string(17) "Energy Management" [2]=> string(37) "Product Design & Lifecycle Management" [3]=> string(5) "R & D" [4]=> string(13) "Collaboration" [5]=> string(17) "Electric Vehicles" } } [8]=> array(7) { ["title_en"]=> string(85) "Cancer Cachexia Market revenue to reach USD 4.5 Billion by 2036, says Research Nester" ["snippet_en"]=> string(156) "Key cancer cachexia market players include Veru, Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Mylan N.V., ANI Pharmaceuticals, Novartis AG,..." ["url"]=> string(156) "https://www.globenewswire.com/news-release/2023/12/07/2792326/0/en/Cancer-Cachexia-Market-revenue-to-reach-USD-4-5-Billion-by-2036-says-Research-Nester.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/27092eaa-9d41-4c66-94cc-b65be7ec8b0b" ["source"]=> string(17) "globenewswire.com" ["publication_date"]=> string(10) "2023-12-07" ["categories"]=> array(3) { [0]=> string(5) "R & D" [1]=> string(11) "Acquisition" [2]=> string(15) "Market Movement" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(254) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(163) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(151) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(94) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(89) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(76) } [6]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(74) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(64) } [8]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(63) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(60) } [10]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(60) } [11]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(56) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(54) } [13]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(47) } [14]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(47) } [15]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(45) } [16]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(45) } [17]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(42) } [18]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(39) } [19]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(35) } [20]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [21]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(33) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(32) } [23]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(22) } [28]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(21) } } } 81631-us-bristol-myers-squibb-company